Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to 0.43.

  • Century Therapeutics' Asset Utilization Ratio rose 631897.92% to 0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year increase of 631897.92%. This contributed to the annual value of 0.02 for FY2024, which is 24986.8% up from last year.
  • Latest data reveals that Century Therapeutics reported Asset Utilization Ratio of 0.43 as of Q3 2025, which was up 631897.92% from 0.38 recorded in Q2 2025.
  • In the past 5 years, Century Therapeutics' Asset Utilization Ratio ranged from a high of 0.43 in Q3 2025 and a low of 0.0 during Q1 2024
  • Its 4-year average for Asset Utilization Ratio is 0.1, with a median of 0.01 in 2022.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 6892.67% in 2024, then surged by 879304.9% in 2025.
  • Over the past 4 years, Century Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.01 in 2022, then plummeted by 43.4% to 0.01 in 2023, then surged by 201.38% to 0.02 in 2024, then surged by 2309.91% to 0.43 in 2025.
  • Its last three reported values are 0.43 in Q3 2025, 0.38 for Q2 2025, and 0.34 during Q1 2025.